{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:27:45Z","timestamp":1791412065986,"version":"4.3.3"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"ZonMw Translational Adult Stem Cell Research Programme","award":["116003005"],"award-info":[{"award-number":["116003005"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.imlet.2017.11.005","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T01:00:17Z","timestamp":1511139617000},"page":"88-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Autologous hematopoietic stem cell transplantation in systemic sclerosis: A reset to tolerance?"],"prefix":"10.1016","volume":"195","author":[{"given":"Femke C.C.","family":"van Rhijn-Brouwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Spierings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imlet.2017.11.005_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/imj.12944","article-title":"The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders","volume":"46","author":"Rebeiro","year":"2016","journal-title":"Intern. Med. J."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.005_bib0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrrheum.2017.7","article-title":"Haematopoietic stem cell transplantation for autoimmune diseases","volume":"13","author":"Swart","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.005_bib0015","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.005_bib0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.berh.2009.12.002","article-title":"Evidence-based management of rapidly progressing systemic sclerosis","volume":"24","author":"Khanna","year":"2010","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"8","key":"10.1016\/j.imlet.2017.11.005_bib0025","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"9790","key":"10.1016\/j.imlet.2017.11.005_bib0030","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet (London England)"},{"issue":"24","key":"10.1016\/j.imlet.2017.11.005_bib0035","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"issue":"Suppl. 10","key":"10.1016\/j.imlet.2017.11.005_bib0040","article-title":"Selected hematopoietic stem cells (HSCT) vs monthly intravenous cyclophosphamide (CYC) for severe scleroderma with internal organ involvement: outcomes of a randomized north american clinical trial [abstract]","volume":"10","author":"Sullivan","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.005_bib0045","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/kel451","article-title":"Skin involvement in scleroderma?where histological and clinical scores meet","volume":"46","author":"Verrecchia","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.imlet.2017.11.005_bib0050","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1371\/journal.pone.0001452","article-title":"Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?","volume":"3","author":"Fleming","year":"2008","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.imlet.2017.11.005_bib0055","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/rheumatology\/kew224","article-title":"BSR and BHPR guideline for the treatment of systemic sclerosis","volume":"55","author":"Denton","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.imlet.2017.11.005_bib0060","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2004.027094","article-title":"Early T cell activation in the skin from patients with systemic sclerosis","volume":"64","author":"Kalogerou","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.005_bib0065","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12016-015-8505-8","article-title":"T and cell phenotypic abnormalities in systemic sclerosis: a cohort study and a comprehensive literature review","volume":"49","author":"Almeida","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2017.11.005_bib0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncprheum0346","article-title":"Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis","volume":"2","author":"Sakkas","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.005_bib0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ard.49.1.40","article-title":"Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis","volume":"49","author":"Gustafsson","year":"1990","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.005_bib0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0091-6749(91)90121-4","article-title":"Altered T cell subpopulations and lymphocytes expressing natural killer cell phenotypes in patients with progressive systemic sclerosis","volume":"87","author":"Frieri","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.005_bib0085","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2133.2009.09213.x","article-title":"Clonal T-cell populations are frequent in the skin and blood of patients with systemic sclerosis","volume":"161","author":"Kreuter","year":"2009","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.005_bib0090","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI71691","article-title":"T cell repertoire following autologous stem cell transplantation for multiple sclerosis","volume":"124","author":"Muraro","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.11.005_bib0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2017.00167","article-title":"Immunological balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes","volume":"8","author":"Malmegrim","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.005_bib0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/imm.12245","article-title":"Immunological characteristics and T-cell receptor clonal diversity in children with systemic juvenile idiopathic arthritis undergoing T-cell-depleted autologous stem cell transplantation","volume":"142","author":"Wu","year":"2014","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.imlet.2017.11.005_bib0105","doi-asserted-by":"crossref","first-page":"e5981","DOI":"10.1371\/journal.pone.0005981","article-title":"Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.imlet.2017.11.005_bib0110","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-016-8563-6","article-title":"Regulatory T cells in systemic sclerosis: a comprehensive review","volume":"52","author":"Slobodin","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2017.11.005_bib0115","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1182\/blood-2007-12-128488","article-title":"Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells","volume":"111","author":"Roord","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.imlet.2017.11.005_bib0120","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood-2005-07-2800","article-title":"Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+\u2009CD25+ immune regulatory network","volume":"107","author":"de Kleer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2017.11.005_bib0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2016.06.005","article-title":"Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation","volume":"169","author":"Arruda","year":"2016","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.005_bib0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.imlet.2017.11.005_bib0135","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","article-title":"Quantitative genetic variation in CD19 expression correlates with autoimmunity","volume":"165","author":"Sato","year":"2000","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.005_bib0140","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","article-title":"Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.005_bib0145","first-page":"59","article-title":"Polyclonal B lymphocyte activation in progressive systemic sclerosis","volume":"29","author":"Famularo","year":"1989","journal-title":"J. Clin. Lab. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.005_bib0150","doi-asserted-by":"crossref","first-page":"R168","DOI":"10.1186\/ar4352","article-title":"B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis","volume":"15","author":"Francois","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.005_bib0155","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.imlet.2017.11.005_bib0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13045-016-0388-5","article-title":"Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients","volume":"10","author":"Farge","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.005_bib0165","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/art.21036","article-title":"Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis","volume":"52","author":"Farge","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.005_bib0170","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3899\/jrheum.081025","article-title":"Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppression","volume":"36","author":"Bohgaki","year":"2009","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.005_bib0175","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/rheumatology\/keq414","article-title":"Analysis of immune reconstitution after autologous CD34+ stem\/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells","volume":"50","author":"Tsukamoto","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.imlet.2017.11.005_bib0180","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","article-title":"High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study","volume":"110","author":"Nash","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.imlet.2017.11.005_bib0185","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1365-2141.2002.03895.x","article-title":"Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study","volume":"119","author":"Farge","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.005_bib0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/bmt.2013.202","article-title":"Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study","volume":"49","author":"Baraut","year":"2014","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.005_bib0195","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/ket419","article-title":"Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature","volume":"53","author":"Colaci","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.imlet.2017.11.005_bib0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clim.2004.07.006","article-title":"Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)","volume":"113","author":"Storek","year":"2004","journal-title":"Clin. Immunol."},{"issue":"Suppl. 104","key":"10.1016\/j.imlet.2017.11.005_bib0205","first-page":"11","article-title":"Thymic findings before and after autologous stem cell transplantation for severe systemic sclerosis: a retrospective study using computed tomography in the pre- and post-transplantation setting","volume":"35","author":"Henes","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.005_bib0210","first-page":"451","article-title":"Analysis of anti-topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation","volume":"56","author":"Henes","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.imlet.2017.11.005_bib0215","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/bmt.2016.77","article-title":"Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients","volume":"51","author":"Michel","year":"2016","journal-title":"Bone Marrow Transplant."},{"issue":"Suppl. 10","key":"10.1016\/j.imlet.2017.11.005_bib0220","article-title":"Immunoablation followed by autologous stem cell transplantation in systemic sclerosis patients decreases significantly the interferon signatrue [abstract]","volume":"67","author":"Assassi","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.005_bib0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2172-10-52","article-title":"Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays","volume":"10","author":"de Jager","year":"2009","journal-title":"BMC. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.005_bib0230","first-page":"275","article-title":"Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis","volume":"33","author":"Matsushita","year":"2006","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.005_bib0235","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/bmt.2016.126","article-title":"Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?","volume":"51","author":"Oliveira","year":"2016","journal-title":"Bone Marrow Transplant."},{"issue":"1\u20132","key":"10.1016\/j.imlet.2017.11.005_bib0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00281-004-0162-6","article-title":"Non-myeloablative stem cell transplantation for autoimmune diseases","volume":"26","author":"Burt","year":"2004","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.imlet.2017.11.005_bib0245","series-title":"European League Against Rheumatism Online Course on Systemic Sclerosis, European League Against Rheumatism","article-title":"Module 9F \u2013 management \u2013 hematopoietic stem cell transplantation","author":"van Rhijn-Brouwer","year":"2016"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817304091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817304091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:28:29Z","timestamp":1547684909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817304091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":49,"alternative-id":["S0165247817304091"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.11.005","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autologous hematopoietic stem cell transplantation in systemic sclerosis: A reset to tolerance?","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}]}}